---
$id: https://graph.org.ai/products/commodity/51292603
$type: Product
source: UNSPSC
code: "51292603"
title: "Aptazapine"
class: "51292600"
classTitle: "Antidepressant benzodiazepines"
family: "51290000"
familyTitle: "Antidepressants"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Aptazapine

**UNSPSC Code**: 51292603
**Class**: [Antidepressant benzodiazepines](Antidepressant benzodiazepines.mdx)
**Family**: [Antidepressants](../Antidepressants.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an antidepressant agent with the molecular formula C16H19N3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier, 240J927J1R chemically known as (+/-)-1,3,4,14b-tetrahydro-2-methyl-2h,10h-pyrazino(1,2-a)pyrrolo(2,1-c)(1,4)benzodiazepine but generally known as aptazapine, which bears US NIH Compound Identifier 51355. European Medicines Agency schedules Aptazapine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05547MIG. The term APTAZAPINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 38, no. 6, 1984, list 24. ). Most nations schedule aptazapine under HS 29335995 and SITC 51576. As of Q4 2014, APTAZAPINE remains the US FDA Preferred Term for this commodity. Aptazapine bears US NLM identifiers UMLS ID C0052237 and NCI Concept Code C79525. SMILES: CN1CCN2C(C1)C3=CC=CN3CC4=CC=CC=C42.

